Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer. - Wikidata - wikimedia - TriplyDB

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

http://www.wikidata.org/entity/Q34734131

about

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains.Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review.

P2860

Q36616750-FF494C2D-378D-4832-8A4D-67BD9894739E Q37186518-67D2EE14-9EB1-4BF7-95F2-6B5203EEF971 Q37873924-7101D111-9CA4-4327-9B49-DB7CE3EC244D Q38059513-D5754E81-9201-4421-9F93-51AA56E8E8F1

P2860

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

http://www.wikidata.org/entity/Q34734131

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@ast

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@en

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@nl

type

label

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@ast

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@en

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@nl

prefLabel

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@ast

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@en

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@nl

P1433

Q34734131-ABE0540F-E9F2-4E3F-8B7B-276F667F7985

P1476

Q34734131-45C232DC-9549-401F-BBD6-2E6FDB886680

P2093

Q34734131-33107387-70AF-48DA-94A2-1E4521A6D7F3

Q34734131-3B401C22-0E6F-481A-A366-3107802788C2

Q34734131-4F1E7D28-1AF3-4B01-93D9-0B1406D9AE7E

Q34734131-8059F1FB-B9FE-473C-A4DD-6767F953D275

Q34734131-BE59DF5B-2E33-4D9C-AFC7-0538C647BAF6

Q34734131-F40545AC-3C01-4712-8D94-0E5762D9E0D5

P2860

Q34734131-07F32430-0D0C-4672-B7BB-2B00B718F88E

Q34734131-083016E0-87E2-4508-A4FF-3B0060D4A980

Q34734131-0E7844A8-C965-404D-81A3-3F850B46F35D

Q34734131-127AFEAB-548C-49E2-A126-3004B6E6F729

Q34734131-15575895-E507-4610-9A5A-C4BAC9046455

Q34734131-1B625EB9-A94C-4162-8CF7-34F6D30C639E

Q34734131-1B897E4F-C30B-4EBC-B304-4CA1CE3D5460

Q34734131-35F69793-4DC3-4ABB-95C1-8FE1380A2795

Q34734131-46A71BE4-DF5C-40DB-BBAB-261858590F8C

Q34734131-78A2E6D4-8789-4A00-8156-20EBB48E260A

P304

Q34734131-5E935FE7-CA5F-40C7-9AAF-8A8B6EB4FD65

P31

Q34734131-7266FE7C-ECD4-4E2D-AC36-ACF603F7A996

P356

Q34734131-754BBE0E-2175-4854-B74C-742992AAE1DC

P433

Q34734131-7D4F782F-7006-48F8-97A3-270AA9C14AF0

P478

Q34734131-2121EEA8-7B2D-4E61-80F7-684875A699F0

P577

Q34734131-E326327A-579D-414A-8A71-761D3BBE06E1

P698

Q34734131-83F4079C-CDE4-4539-94BF-6714E952069C

P921

Q34734131-3CFB5343-1910-4648-8A5F-27907BC67123

Q34734131-675791F4-9E5B-4801-85DE-44CC04CB5CF4

P356

14737140.2.1.97

P1433

Expert Review of Anticancer Therapy

P1476

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

@en

P2093

Alessandro D Santin

http://www.w3.org/2001/XMLSchema#string

Kristina L Bondurant

http://www.w3.org/2001/XMLSchema#string

L Joey Underwood

http://www.w3.org/2001/XMLSchema#string

Mark D Crew

http://www.w3.org/2001/XMLSchema#string

Martin J Cannon

http://www.w3.org/2001/XMLSchema#string

Timothy J O'Brien

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian tumor cells express a novel multi-domain cell surface serine protease

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention

Dendritic cells: specialized and regulated antigen processing machines

Dendritic cell vaccines for cancer immunotherapy.

The CA 125 gene: an extracellular superstructure dominated by repeat sequences.

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

Regulation of T cell immunity by dendritic cells.

Dendritic cells as vectors for therapy.

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.

P304

97-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2.1.97

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12113075

http://www.w3.org/2001/XMLSchema#string

P921